These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 11673661

  • 1. The chimeric mouse-human anti-CD4 Fab 13B8.2 expressed in baculovirus inhibits both antigen presentation and HIV-1 promoter activation.
    Bès C, Cerutti M, Briant-Longuet L, Bresson D, Peraldi-Roux S, Pugnière M, Mani JC, Pau B, Devaux C, Granier C, Devauchelle G, Chardès T.
    Hum Antibodies; 2001; 10(2):67-76. PubMed ID: 11673661
    [Abstract] [Full Text] [Related]

  • 2. Biological activities on T lymphocytes of a baculovirus-expressed chimeric recombinant IgG1 antibody with specificity for the CDR3-like loop on the D1 domain of the CD4 molecule.
    Troadec S, Bès C, Chentouf M, Nguyen B, Briant L, Jacquet C, Chebli K, Pugnière M, Roquet F, Cerutti M, Chardès T.
    Clin Immunol; 2006 Apr; 119(1):38-50. PubMed ID: 16426893
    [Abstract] [Full Text] [Related]

  • 3. An anti-CD4 (CDR3-loop) monoclonal antibody inhibits human immunodeficiency virus type 1 envelope glycoprotein-induced apoptosis.
    Guillerm C, Robert-Hebmann V, Hibner U, Hirn M, Devaux C.
    Virology; 1998 Sep 01; 248(2):254-63. PubMed ID: 9721234
    [Abstract] [Full Text] [Related]

  • 4. In vitro antitumoral activity of baculovirus-expressed chimeric recombinant anti-CD4 antibody 13B8.2 on T-cell lymphomas.
    Troadec S, Chentouf M, Cérutti M, Nguyen B, Olive D, Bès C, Chardès T.
    J Immunother; 2007 Sep 01; 30(2):190-202. PubMed ID: 17471166
    [Abstract] [Full Text] [Related]

  • 5. An antibody that binds domain 1 of CD4 inhibits replication of HIV-1, but not HTLV-I, in a CD4-positive/p56lck-negative HTLV-I-transformed cell line.
    Lemasson I, Briant L, Hague B, Coudronnière N, Heron L, David C, Rebouissou C, Kindt T, Devaux C.
    J Immunol; 1996 Jan 15; 156(2):859-65. PubMed ID: 8543843
    [Abstract] [Full Text] [Related]

  • 6. Functional humanization of an anti-CD16 Fab fragment: obstacles of switching from murine {lambda} to human {lambda} or {kappa} light chains.
    Schlapschy M, Fogarasi M, Gruber H, Gresch O, Schäfer C, Aguib Y, Skerra A.
    Protein Eng Des Sel; 2009 Mar 15; 22(3):175-88. PubMed ID: 19022801
    [Abstract] [Full Text] [Related]

  • 7. Mapping the paratope of anti-CD4 recombinant Fab 13B8.2 by combining parallel peptide synthesis and site-directed mutagenesis.
    Bès C, Briant-Longuet L, Cerutti M, Heitz F, Troadec S, Pugnière M, Roquet F, Molina F, Casset F, Bresson D, Péraldi-Roux S, Devauchelle G, Devaux C, Granier C, Chardes T.
    J Biol Chem; 2003 Apr 18; 278(16):14265-73. PubMed ID: 12566463
    [Abstract] [Full Text] [Related]

  • 8. Identification of a novel CD4i human monoclonal antibody Fab that neutralizes HIV-1 primary isolates from different clades.
    Zhang MY, Shu Y, Sidorov I, Dimitrov DS.
    Antiviral Res; 2004 Mar 18; 61(3):161-4. PubMed ID: 15168796
    [Abstract] [Full Text] [Related]

  • 9. Bacterial expression of a human recombinant monoclonal antibody fab fragment against hepatitis B surface antigen.
    Maeda F, Nagatsuka Y, Ihara S, Aotsuka S, Ono Y, Inoko H, Takekoshi M.
    J Med Virol; 1999 Aug 18; 58(4):338-45. PubMed ID: 10421399
    [Abstract] [Full Text] [Related]

  • 10. HIV-1 neutralization by chimeric CD4-CG10 polypeptides fused to human IgG1.
    Meyuhas R, Noy H, Montefiori DC, Denisova G, Gershoni JM, Gross G.
    Mol Immunol; 2005 May 18; 42(9):1099-109. PubMed ID: 15829299
    [Abstract] [Full Text] [Related]

  • 11. Efficient CD4 binding and immunosuppressive properties of the 13B8.2 monoclonal antibody are displayed by its CDR-H1-derived peptide CB1.
    Bès C, Briant-Longuet L, Cerruti M, De Berardinis P, Devauchelle G, Devaux C, Granier C, Chardès T.
    FEBS Lett; 2001 Nov 09; 508(1):67-74. PubMed ID: 11707270
    [Abstract] [Full Text] [Related]

  • 12. Human antibodies to HIV-1 by recombinant DNA methods.
    Burton DR, Barbas CF.
    Chem Immunol; 1993 Nov 09; 56():112-26. PubMed ID: 8452652
    [No Abstract] [Full Text] [Related]

  • 13. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
    Chakraborty K, Durani V, Miranda ER, Citron M, Liang X, Schleif W, Joyce JG, Varadarajan R.
    Biochem J; 2006 Nov 01; 399(3):483-91. PubMed ID: 16827663
    [Abstract] [Full Text] [Related]

  • 14. Recognition of defined epitopes by affinity-purified anti-immunoglobulin fab autoantibodies isolated from HIV-infected humans.
    Marchalonis JJ, Garza A, Lake DF, Landsperger WJ, Süsal C.
    J Mol Recognit; 1999 Nov 01; 12(3):169-76. PubMed ID: 10398407
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Preliminary crystallographic studies of an anti-HIV-1 protease antibody that inhibits enzyme activity.
    Lescar J, Stouracova R, Riottot MM, Chitarra V, Brynda J, Fabry M, Horejsi M, Sedlacek J, Bentley GA.
    Protein Sci; 1996 May 01; 5(5):966-8. PubMed ID: 8732768
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Construction and expression of mouse-human chimeric Fab fragment gene of monoclonal antibody SZ-2 against platelet].
    Dai KS, Zhu HP, Jiang M, Ruan CG.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan 01; 19(1):71-3, 79. PubMed ID: 15132913
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.